Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
18 hedge funds and large institutions have $11.8M invested in Acer Therapeutics Inc in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
53% more capital invested
Capital invested by funds: $7.7M → $11.8M (+$4.08M)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
13% more funds holding
Funds holding: 16 → 18 (+2)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.59M |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$1.02M |
| 3 |
MWNA
Marshall Wace North America
New York
|
+$368K |
| 4 |
Neuberger Berman Group
New York
|
+$367K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$264K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$2.09M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.39M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$896K |
| 4 |
JGC
J. Goldman & Co
New York
|
-$326K |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$36K |
ACER Hedge Fund Activity: Q1 2018 in Review
18 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q1 2018, worth a combined $11.8M — up 53% from $7.7M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ACER positions and 4 closed out — a net gain of 2 holders — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Nantahala Capital Management, opening a new position worth an estimated $4.59M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $2.09M sold.
- 18 institutional investors held Acer Therapeutics Inc (ACER) as of Q1 2018, up from 16 in Q4 2017.
- Funds reported $11.8M of Acer Therapeutics Inc stock for Q1 2018, up 53% quarter-over-quarter.
- 6 funds opened new Acer Therapeutics Inc positions in Q1 2018 and 4 closed out, a net change of +2 holders.
- The largest Acer Therapeutics Inc buyer in Q1 2018 was Nantahala Capital Management, an estimated $4.59M added.
- The largest Acer Therapeutics Inc seller in Q1 2018 was Perceptive Advisors, an estimated $2.09M sold.
Based on aggregated 13F filings for Q1 2018.